By Amanda Bronstad | October 27, 2022
In trial briefs filed ahead of a second phase of trial this month, lawyers for the city and county of San Francisco said they would need $8.1 billion to fix the opioid crisis, a figure Walgreens called "wildly excessive."
By Mason Lawlor | October 7, 2022
Noah Foley was 11 years old when he received the Gardasil shot in May 2018. He had a clean bill of health until two weeks after receiving the vaccine, when he experienced inflammation in the lymph nodes and an abnormal white blood cell count, according to the complaint.
By Hugo Guzman | October 6, 2022
The German pharmaceutical giant handed the role to an attorney who played a key role in helping the company resolve a deluge of lawsuits over its weedkiller Roundup.
By Scott Graham | October 3, 2022
The justices have plucked from obscurity a case about smart watch patents and once again asked the solicitor general for its views on patent eligibility. The justices also ask for the SG's views on a Hatch-Waxman case involving induced infringement.
By Scott Graham | September 8, 2022
Crowell & Morning partner Virginia Wolk Marino says clearing new brand names with the USPTO and the FDA is an increasingly tricky challenge. That's why the newest pharmaceuticals often sport four syllables and novel letter combinations.
By Brian Lee | August 30, 2022
A cashier's personal beliefs can not restrict access to products including birth control, condoms, emergency contraceptives, and other medications, New York Attorney General Letitia James said.
By Amanda Bronstad | August 17, 2022
U.S. District Judge Dan Polster, on Wednesday, ordered the three pharmacies to provide abatement funds to two Ohio counties who won a Nov. 23 verdict over the opioid crisis.
By Alaina Lancaster | August 10, 2022
The bench ruling from U.S. District Judge Charles Breyer marks the first bench trial to find Walgreens liable for public nuisance claims in the nationwide multidistrict litigation stemming from the ongoing opioid epidemic, according to San Francisco City Attorney David Chiu.
By Amanda Bronstad | July 29, 2022
Allergan's $2.37 billion settlement, reached with a bipartisan group of state attorneys general to resolve lawsuits over the opioid crisis, comes five days after another drug manufacturer, Teva, reached a $4.25 billion deal.
By Amanda Bronstad | July 26, 2022
Under the settlement, announced on Tuesday, Teva would provide $3.7 billion to states, local communities and Native American tribes, plus $1.2 billion worth of generic Narcan, a nasal spray used to treat opioid overdoses.
Presented by BigVoodoo
The National Law Journal honors attorneys & judges who've made a remarkable difference in the legal profession in the D.C. area.
The New England Legal Awards serves as a testament to the outstanding contributions and achievements made by legal professionals.
Join the industry's top owners, investors, developers, brokers & financiers at THE MULTIFAMILY EVENT OF THE YEAR!
Mid sized NYC Personal Injury Defense Firm seeking to immediately hire several attorneys to join our firm. Preferred candidates are those w...
Mid-size Parsippany based law firm with a statewide practice is searching for a full-time motivated associate litigation attorney with 3-5 y...
Description: Fox Rothschild has an opening in Princeton, NJ for an associate in the Litigation Department. The ideal candidate will have tw...